Prospective Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. Nov 28, 2015; 21(44): 12667-12675
Published online Nov 28, 2015. doi: 10.3748/wjg.v21.i44.12667
Figure 5
Figure 5 Comparison of prevalence rate of Epstein-Barr virus infection in 3 groups, including the immunocompetent patients excluding ulcerative colitis, the immunocompromised patients excluding ulcerative colitis, and ulcerative colitis patients. EBV: Epstein-Barr virus.